University of Michigan: Nanoparticle Relieved Symptoms of Inflammatory Bowel Disease in Mice
August 20, 2019
August 20, 2019
ANN ARBOR, Michigan, Aug. 20 [TNSmedicalresearch] -- The University of Michigan issued the following news release:
Researchers at the University of Michigan College of Pharmacy have developed a nanoparticle that alters the gut microbiome and alleviates symptoms of inflammatory bowel disease in mice more effectively than common FDA-approved medications.
The gut microbiome--the body's environment of healthy and unhealthy bacteria--is the next frontier for drug develo . . .
Researchers at the University of Michigan College of Pharmacy have developed a nanoparticle that alters the gut microbiome and alleviates symptoms of inflammatory bowel disease in mice more effectively than common FDA-approved medications.
The gut microbiome--the body's environment of healthy and unhealthy bacteria--is the next frontier for drug develo . . .